Vertex Pharmaceuticals (VRTX) Profit After Tax Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | 33.04% |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | 30.60% |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -154.28% |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | 13.80% |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | -3.84% |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | 16.53% |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | 47.10% |
| 10 | Revolution Medicines | 30.42 Bn | 30.42 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.80% |
| Dec 31, 2025 | 13.30% |
| Sep 30, 2025 | 5.19% |
| Jun 30, 2025 | 8.42% |
| Mar 31, 2025 | -5.35% |
| Dec 31, 2024 | 5.84% |
| Sep 30, 2024 | 7.06% |
| Jun 30, 2024 | -281.76% |
| Mar 31, 2024 | 18.96% |
| Dec 31, 2023 | 17.05% |
| Sep 30, 2023 | 15.76% |
| Jun 30, 2023 | 3.03% |
| Mar 31, 2023 | 5.10% |
| Dec 31, 2022 | 11.98% |
| Sep 30, 2022 | 152.91% |
| Jun 30, 2022 | 44.72% |
| Mar 31, 2022 | 41.56% |
| Dec 31, 2021 | -20.81% |
| Sep 30, 2021 | 87.74% |
| Jun 30, 2021 | -31.38% |
| Mar 31, 2021 | 45.91% |
| Dec 31, 2020 | 81.72% |
| Sep 30, 2020 | 62.51% |
| Jun 30, 2020 | 259.66% |
| Mar 31, 2020 | 34.17% |
| Dec 31, 2019 | 175.94% |
| Sep 30, 2019 | 51.55% |
| Jun 30, 2019 | 111.03% |
| Mar 31, 2019 | 103.70% |
| Dec 31, 2018 | 183.42% |
| Sep 30, 2018 | 49.96% |
| Jun 30, 2018 | 43.23% |
| Mar 31, 2018 | 45.16% |
| Dec 31, 2017 | 36.74% |
| Sep 30, 2017 | -19.65% |
| Jun 30, 2017 | 28.32% |
| Mar 31, 2017 | 45.42% |
| Dec 31, 2016 | 49.28% |
| Sep 30, 2016 | 32.11% |
| Jun 30, 2016 | 14.17% |